{"database": "lobbying", "table": "lobbying_activities", "rows": [[2635050, "5dbab130-0fbd-4032-aa13-0517058bf97c", "Q2", "PANNONE LOPES DEVEREAUX & O'GARA LLC", 401105501, "AMGEN", 2021, "second_quarter", "PHA", "Prescription drug pricing.", null, 9000, null, 0, 0, "2021-07-12T09:09:55.760000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2635050"], "units": {}, "query_ms": 4.731735913082957, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}